首轨生物治疗 TRAX
$47.90 +$2.47 (+5.44%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $49.00 +2.30%
开盘$45.94
昨收$45.43
当日区间$45.35 – $48.24
成交量590.3K
市值$2.01B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$34.94M+23.9% YoY
净利润-$33.37M+21.4% YoY
摊薄每股收益-$0.95+22.2% YoY
自由现金流-$31.94M+17.4% YoY
经营现金流-$31.92M
营收，近4个季度
净利润，近4个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
流动比率14.28
负债/资产比率7.8%
现金及投资$168.02M
总负债$1.90M
净现金（净负债）$166.12M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 Q2 | 2025 Q1 | 2024 ANNUAL |
|---|---|---|---|---|---|
| 净利润 | -$33.37M | -$50.48M | -$42.45M | -$47.20M | -$163.71M |
| 归属母公司净利润 | -$33.37M | -$50.48M | -$42.45M | -$47.20M | -$163.71M |
| 归属普通股股东净利润 | -$33.37M | -$50.48M | -$42.45M | -$47.20M | -$163.71M |
| 基本每股收益 | -$0.95 | -$1.45 | -$1.22 | -$1.36 | -$4.71 |
| 摊薄每股收益 | -$0.95 | -$1.45 | -$1.22 | -$1.36 | -$4.71 |
| 持续经营利润 | -$33.37M | -$50.48M | -$42.45M | -$47.20M | -$163.71M |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 销售及管理费用 | $9.29M | $18.86M | $6.63M | $9.82M | $28.76M |
| -管理费用 | $9.29M | $18.86M | $6.63M | $9.82M | $28.76M |
| 研发费用 | $25.64M | $33.96M | $39.27M | $41.47M | $152.35M |
| 营业利润 | -$34.94M | -$52.81M | -$45.90M | -$51.28M | -$181.10M |
| 非经营性利息净收入（支出） | $1.56M | $2.33M | $3.47M | $4.09M | $17.38M |
| 非经营性利息收入 | $1.56M | $2.33M | $3.47M | $4.09M | $17.38M |
| 其他收入（支出） | -$1,000.00 | -$1,000.00 | -$13,000.00 | -$7,000.00 | $14,000.00 |
| 其他非经营性收入（支出） | -$1,000.00 | -$1,000.00 | -$13,000.00 | -$7,000.00 | $14,000.00 |
| 税前利润 | -$33.37M | -$50.48M | -$42.45M | -$47.20M | -$163.71M |
| 营业费用 | $34.94M | $52.81M | $45.90M | $51.28M | $181.10M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2024 ANNUAL | 2023 ANNUAL |
|---|---|---|---|---|
| 不影响留存收益的损益 | $0.00 | -$146,000.00 | $305,000.00 | -$797,000.00 |
| 留存收益 | -$24.58M | – | – | – |
| 资本公积 | $193.34M | – | – | – |
| -优先股 | $0.00 | – | – | – |
| -普通股 | $35,000.00 | – | – | – |
| 流动负债合计 | $12.45M | $33.11M | $36.18M | $18.22M |
| 股本 | $35,000.00 | – | – | – |
| 股东权益 | $168.80M | $257.46M | $391.60M | $409.85M |
| -现金及现金等价物 | $168.02M | $248.47M | $123.08M | $35.97M |
| -短期投资 | $0.00 | $37.99M | $262.29M | $354.94M |
| 应收款 | $5.07M | – | – | – |
| -其他应收款 | $5.07M | – | – | – |
| 预付资产 | $2.47M | – | – | – |
| 其他流动资产 | $2.18M | $2.95M | $4.56M | $7.65M |
| 非流动资产合计 | $5.40M | $1.17M | $51.96M | $45.55M |
| 固定资产净值 | $5.40M | $1.17M | $16.23M | $18.27M |
| -固定资产原值 | $12.67M | $8.35M | $22.83M | $24.49M |
| -累计折旧 | -$7.28M | -$7.17M | -$6.60M | -$6.22M |
| 现金及现金等价物与短期投资 | $168.02M | $286.46M | $385.37M | $390.90M |
| 流动资产合计 | $177.75M | $289.40M | $389.93M | $398.56M |
| 股东权益合计 | $168.80M | $257.46M | $391.60M | $409.85M |
| -长期融资租赁负债 | $1.90M | $0.00 | $14.11M | $16.04M |
| 长期债务及融资租赁负债 | $1.90M | $0.00 | $14.11M | $16.04M |
| 非流动负债合计 | $1.90M | $0.00 | $14.11M | $16.04M |
| -一年内到期融资租赁负债 | $2.44M | $0.00 | $1.93M | $1.78M |
| 短期债务及融资租赁负债 | $2.44M | – | $1.93M | $1.78M |
| 一年内应计费用 | $5.49M | $20.76M | $23.05M | $9.43M |
| -应付账款 | $2.55M | $7.50M | $3.79M | $2.43M |
| 应付款 | $2.55M | $7.50M | $3.79M | $2.43M |
| 总资产 | $183.14M | $290.58M | $441.89M | $444.11M |
| 负债合计 | $14.34M | $33.11M | $50.30M | $34.26M |
| 其他权益权益 | – | $257.61M | $391.29M | $410.65M |
| 投资及预付款 | – | – | $35.47M | $27.03M |
| 其他非流动资产 | – | – | $256,000.00 | $256,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 Q2 | 2025 Q1 | 2024 ANNUAL |
|---|---|---|---|---|---|
| 经营活动现金流 | -$31.92M | -$32.56M | -$38.64M | -$45.01M | -$125.81M |
| 期末现金余额 | $168.02M | $248.47M | $44.30M | $98.64M | $123.08M |
| 其他筹资费用净额 | -$235.07M | $7.85M | -$52.11M | $5.72M | $117.52M |
| 持续经营筹资活动现金流净额 | -$48.51M | $7.85M | -$52.11M | $5.72M | $117.52M |
| 筹资活动现金流 | -$48.51M | $7.85M | -$52.11M | $5.72M | $117.52M |
| 投资购置及出售净额 | $0.00 | $35.00M | $36.44M | $14.88M | $95.76M |
| 营运资金变动 | -$7.22M | $6.30M | -$2.85M | -$4.50M | $18.99M |
| 固定资产购置及出售净额 | -$25,000.00 | -$17,000.00 | -$39,000.00 | -$35,000.00 | -$358,000.00 |
| 持续经营投资活动现金流净额 | -$25,000.00 | $34.98M | $36.40M | $14.85M | $95.40M |
| 投资活动现金流净额 | -$25,000.00 | $34.98M | $36.40M | $14.85M | $95.40M |
| -其他流动负债变动 | -$93,000.00 | $0.00 | -$479,000.00 | -$462,000.00 | -$1.78M |
| -应付账款及应计费用变动 | $5.24M | $4.15M | -$3.46M | -$3.59M | $17.81M |
| -预付资产变动 | -$12.36M | $2.16M | $1.08M | -$443,000.00 | $2.95M |
| 持续经营净利润 | -$33.37M | -$50.48M | -$42.45M | -$47.20M | -$163.71M |
| 持续经营经营活动现金流净额 | -$31.92M | -$32.56M | -$38.64M | -$45.01M | -$125.81M |
| 折旧、折耗与摊销 | $207,000.00 | $125,000.00 | $601,000.00 | $606,000.00 | $2.40M |
| 自由现金流 | -$31.94M | -$32.58M | -$38.68M | -$45.04M | -$126.16M |
| 现金净变动 | -$80.45M | $10.27M | -$54.34M | -$24.44M | $87.12M |
| 期初现金余额 | $248.47M | $238.20M | $98.64M | $123.08M | $35.97M |
暂无评论——快来第一个聊聊 TRAX。
登录后参与讨论。